Purpose
to determine optimal conditions for therapy with engineered b-cells producing antibodies against global health priority pathogens
Grantee
Division
Global Health
Date
AUGUST 2019
Region served
GLOBAL
Committed amount
$3,436,458
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
61
Grantee location
Seattle, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.